Cardiovascular and Metabolomics Medicine

ABOUT THE PROJECT

Characterize the cellular and molecular mechanisms that contribute to the development of cardiovascular and metabolic diseases to propose and evaluate new experimental therapies for prevention and treatment in preclinical models, which will lay the scientific basis for conducting clinical studies with patients


Research lines

• Study of novel immuno-modulation and thrombosis mechanisms in cardiovascular and metabolic diseases.
• Characterization of pathological alterations in intracellular calcium management during the development of heart failure and arrhythmias.
• Regulation of energy metabolism and mitochondrial function in cardiovascular and metabolic diseases.
• Development of nanomaterials with biomedical applications in the cardiovascular area.
• Development of new molecules of natural origin and micronutrients for the treatment of cardiovascular and metabolic diseases.

Leader

Gerardo de Jesús García Rivas

Core reserchers

Carlos Enrique Guerrero Beltrán
Julio Altamirano Barrera
Luz Leticia Elizondo Montemayor
Noemí García Ramírez

Adjunct researchers

Armando Tellez Cruz
Beatriz Lorenza Rodríguez Martínez
Carlos Jerjes-Sánchez Díaz
Christian Ivan Silva Platas
Eduardo Vázquez Garza
Elena Cristina González Castillo
Estibalitz Laresgoiti Servitje
Francisco Javier Sierra Valdez
Guillermo Torre Amione
Héctor Chapoy Villanueva
José Carlos Campero Basaldúa
Luis Adolfo Sánchez Trujillo
Nestor Rubio Infante
Omar Lozano García

PROJECTS

- Generación de nanovectores funcionalizados con la proteína sorcina (SRI) como estrategia novedosa para el tratamiento de la insuficiencia cardiaca y la arritmogénesis .

- Evaluación de la seguridad y la eficacia de moléculas inmunomoduladoras en el tratamiento de pacientes con insuficiencia cardiaca avanzada.